Germany
David is a highly accomplished and experienced organizational leader, with a track record of over 25 years in diverse roles within product development and international clinical operations across pharmaceutical, biotech, and medical device companies. Currently he is serving as the Global Head of Clinical Development Operations at Boehringer Ingelheim. Fuelled by a passion for industry-leading innovation, David inspires and supports his organisation to accelerate the delivery of groundbreaking healthcare solutions for patients. His commitment to growth and performance is unwavering, fostering a collaborative environment that empowers individuals and propels the organization to achieve extraordinary results.
Responsible for defining and implementing an overarching integrated vision and strategy for the Clinical Development Operations function, focused on excellence in clinical trial execution.
Responsible for providing the leadership and direction to the Global Clinical Operations organization within the EMEA Region, managing end-to-end site-facing operational capabilities with the key goal of delivering Janssen's clinical development programs on time and on budget. Board member of Janssen-Cilag International NV
Leadership of the Global Clinical Operations Western Europe cluster (France, Germany, Italy, UK, Spain, Belgium and The Netherlands). Accountable for flawless trial planning & execution across the cluster and for optimising productivity by building synergies between the Western Europe countries. Accountable for defining and leading a long term sustainable strategy for excellence in trial planning, execution, continuous process improvement and talent development across Western Europe in alignment with the EMEA and Global Clinical Development Operations organisations.
Head of Clinical Trial Management (CTM) function within the Product Development Operations organisation of Janssen, the pharmaceutical division of Johnson & Johnson.
Lead for Amgen's business transformation initiative driving the development of mHealth technologies & capabilities to support a patient-centred clinical development approach
Head of global functions supporting planning and execution of clinical trials including Feasibility & Patient Recruitment, Supplier Governance, Technical Services for labs and imaging, Study Project Planning, Clinical Trial Management Systems and Analytics & Trial Disclosure.
Lead global study teams to deliver the programme of Phase 2 to 4 clinical trials in support of clinical product development across the osteoporosis and neuroscience areas
UK based consultancy providing clinical research, regulatory affairs and health economics services to the international medcial device industry
Management of multi-centre European safety and efficacy studies for pacemaker & pacemaker leads and implantable defibrillator products